Male breast tumours

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The data of 63 male breast cancer patients treated between 1967 and 1990 in the Department of Surgery of the National Institute of Oncology are described. Beside the 59 breast cancer cases four tumours of other histologic type were also detected. As to surgical treatment in addition to mastectomy the axillary block dissection is regarded as important in each case. The prognosis is mainly determined by the time elapsed until treatment and by the lymph node status. The mean survival of the axillary node negative patients was 116 months compared to that of 38.9 months found in axillary node positive cases. Metastases were the soonest detected 2 years following surgery altogether in 36 cases (61%). Local recurrence developed in eight patients (14%). Steroid hormone receptor investigations have been performed since 1980; of the 27 patients examined estrogen receptor positivity was seen in 25 cases. The hormone receptor study of the tumour and the assessment of the hormonal status of the patient provide valuable information for the treatment. In case of tumour progression the life of the patient might considerably be prolonged by combined hormone and cytostatic therapy.

Original languageEnglish
Pages (from-to)581-586
Number of pages6
JournalEuropean Journal of Surgical Oncology
Volume19
Issue number6
Publication statusPublished - 1993

Fingerprint

Male Breast Neoplasms
Hormones
Neoplasms
Steroid Receptors
Mastectomy
Cytostatic Agents
Therapeutics
Estrogen Receptors
Dissection
Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
Recurrence
Survival

Keywords

  • Male breast tumour
  • Therapy

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Male breast tumours. / Sulyok, Z.; Köves, I.

In: European Journal of Surgical Oncology, Vol. 19, No. 6, 1993, p. 581-586.

Research output: Contribution to journalArticle

@article{cc28e02e13aa4332a2691de59e0d9813,
title = "Male breast tumours",
abstract = "The data of 63 male breast cancer patients treated between 1967 and 1990 in the Department of Surgery of the National Institute of Oncology are described. Beside the 59 breast cancer cases four tumours of other histologic type were also detected. As to surgical treatment in addition to mastectomy the axillary block dissection is regarded as important in each case. The prognosis is mainly determined by the time elapsed until treatment and by the lymph node status. The mean survival of the axillary node negative patients was 116 months compared to that of 38.9 months found in axillary node positive cases. Metastases were the soonest detected 2 years following surgery altogether in 36 cases (61{\%}). Local recurrence developed in eight patients (14{\%}). Steroid hormone receptor investigations have been performed since 1980; of the 27 patients examined estrogen receptor positivity was seen in 25 cases. The hormone receptor study of the tumour and the assessment of the hormonal status of the patient provide valuable information for the treatment. In case of tumour progression the life of the patient might considerably be prolonged by combined hormone and cytostatic therapy.",
keywords = "Male breast tumour, Therapy",
author = "Z. Sulyok and I. K{\"o}ves",
year = "1993",
language = "English",
volume = "19",
pages = "581--586",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Male breast tumours

AU - Sulyok, Z.

AU - Köves, I.

PY - 1993

Y1 - 1993

N2 - The data of 63 male breast cancer patients treated between 1967 and 1990 in the Department of Surgery of the National Institute of Oncology are described. Beside the 59 breast cancer cases four tumours of other histologic type were also detected. As to surgical treatment in addition to mastectomy the axillary block dissection is regarded as important in each case. The prognosis is mainly determined by the time elapsed until treatment and by the lymph node status. The mean survival of the axillary node negative patients was 116 months compared to that of 38.9 months found in axillary node positive cases. Metastases were the soonest detected 2 years following surgery altogether in 36 cases (61%). Local recurrence developed in eight patients (14%). Steroid hormone receptor investigations have been performed since 1980; of the 27 patients examined estrogen receptor positivity was seen in 25 cases. The hormone receptor study of the tumour and the assessment of the hormonal status of the patient provide valuable information for the treatment. In case of tumour progression the life of the patient might considerably be prolonged by combined hormone and cytostatic therapy.

AB - The data of 63 male breast cancer patients treated between 1967 and 1990 in the Department of Surgery of the National Institute of Oncology are described. Beside the 59 breast cancer cases four tumours of other histologic type were also detected. As to surgical treatment in addition to mastectomy the axillary block dissection is regarded as important in each case. The prognosis is mainly determined by the time elapsed until treatment and by the lymph node status. The mean survival of the axillary node negative patients was 116 months compared to that of 38.9 months found in axillary node positive cases. Metastases were the soonest detected 2 years following surgery altogether in 36 cases (61%). Local recurrence developed in eight patients (14%). Steroid hormone receptor investigations have been performed since 1980; of the 27 patients examined estrogen receptor positivity was seen in 25 cases. The hormone receptor study of the tumour and the assessment of the hormonal status of the patient provide valuable information for the treatment. In case of tumour progression the life of the patient might considerably be prolonged by combined hormone and cytostatic therapy.

KW - Male breast tumour

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0027751718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027751718&partnerID=8YFLogxK

M3 - Article

C2 - 8270048

AN - SCOPUS:0027751718

VL - 19

SP - 581

EP - 586

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 6

ER -